Japanese Foundation For Cancer Research

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell

Hematopoietic stem cells (HSCs) supply all blood cells throughout life by making use of their self-renewal and multilineage differentiation capabilities. A monoclonal antibody r...

A cross-population atlas of genetic associations for 220 human phenotypes

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-positive metastatic breast cancer. In addition to nausea and myelosuppressi...

RET, ROS1 and ALK fusions in lung cancer

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

Nucleotide sequence of a cloned fragment of rat mitochondrial DNA containing the replication origin

Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma